Want to join the conversation?
$LRCX expects 1Q17 revenue of $1.55-1.7Bil, gross margin of 43.2-45.2% and operating margin of 19.2-21.2%. The company predicts 1Q17 EPS of $1.38-1.58 and non-GAAP EPS of $1.67-1.87. $LRCX projects shipments of $1.625-1.775Bil. Diluted share count is expected to be 178MM on GAAP basis and 176MM on non-GAAP basis.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?